Bioceres Crop Solutions Corp. (BIOX) Financial Ratios
9 years of historical data (2017–2025) · Basic Materials · Agricultural Inputs
EV/EBITDA
↑
19.54
+1% vs avg
5yr avg: 19.40
30Y Low7.1·High38.4
P/FCF
↓
0.67
↓-97% vs avg
5yr avg: 22.80
30Y Low6.2·High45.8
P/B Ratio
↓
0.08
↓-97% vs avg
5yr avg: 3.06
30Y Low1.0·High8.2
ROE
↓
-16.0%
↑-259% vs avg
5yr avg: -4.5%
30Y Low-39%·High8%
Debt/EBITDA
↑
20.20
↑+187% vs avg
5yr avg: 7.03
30Y Low2.8·High20.2
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
BIOX Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Bioceres Crop Solutions Corp. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 0.7x P/FCF, 97% below the 5-year average of 22.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $24M | $283M | $712M | $844M | $580M | $551M | $221M | $162M | $272M | — |
| Enterprise Value | $267M | $526M | $938M | $1.1B | $716M | $690M | $343M | $262M | $361M | — |
| P/E Ratio → | -0.45 | — | 219.37 | 44.53 | — | — | 65.73 | — | — | — |
| P/S Ratio | 0.07 | 0.85 | 1.53 | 2.01 | 1.77 | 2.67 | 1.28 | 1.01 | 2.04 | — |
| P/B Ratio | 0.08 | 0.96 | 2.03 | 2.55 | 3.66 | 6.10 | 3.68 | 2.60 | 8.22 | — |
| P/FCF | 0.67 | 8.00 | 37.59 | — | — | — | 45.82 | 6.15 | 21.47 | — |
| P/OCF | 0.47 | 5.66 | 17.06 | 326.08 | — | — | 23.68 | 5.44 | 14.81 | — |
P/E links to full P/E history page with 30-year chart
BIOX EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Bioceres Crop Solutions Corp.'s enterprise value stands at 19.5x EBITDA, roughly in line with its 5-year average of 19.4x. The Basic Materials sector median is 11.0x, placing the stock at a 77% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.58 | 2.02 | 2.51 | 2.18 | 3.34 | 1.99 | 1.63 | 2.70 | — |
| EV / EBITDA | 19.54 | 38.45 | 14.19 | 14.32 | 14.60 | 15.44 | 7.82 | 7.09 | 17.98 | — |
| EV / EBIT | — | — | 27.46 | 19.88 | 18.50 | 18.42 | 13.29 | 20.99 | — | — |
| EV / FCF | — | 14.91 | 49.55 | — | — | — | 71.28 | 9.97 | 28.48 | — |
BIOX Profitability
Margins and return-on-capital ratios measuring operating efficiency
Bioceres Crop Solutions Corp. earns an operating margin of -1.1%, below the Basic Materials sector average of 10.3%. Operating margins have compressed from 12.9% to -1.1% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -16.0% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.1% | 39.1% | 39.1% | 43.0% | 38.5% | 44.0% | 46.1% | 45.9% | 42.2% | 36.1% |
| Operating Margin | -1.1% | -1.1% | 9.6% | 12.9% | 12.1% | 18.6% | 22.7% | 20.0% | 11.8% | -0.8% |
| Net Profit Margin | -15.5% | -15.5% | 0.7% | 4.5% | -2.2% | -3.3% | 1.9% | -11.5% | -8.3% | -12.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -16.0% | -16.0% | 1.0% | 7.7% | -5.8% | -9.1% | 5.5% | -38.6% | -19.6% | -14.8% |
| ROA | -6.4% | -6.4% | 0.4% | 2.8% | -1.6% | -2.0% | 1.2% | -8.4% | -5.1% | -4.9% |
| ROIC | -0.5% | -0.5% | 6.0% | 9.7% | 11.4% | 14.0% | 17.0% | 16.9% | 8.6% | -0.3% |
| ROCE | -0.8% | -0.8% | 8.6% | 13.3% | 15.3% | 19.5% | 26.7% | 31.5% | 12.6% | -0.4% |
BIOX Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Bioceres Crop Solutions Corp. carries a Debt/EBITDA ratio of 20.2x, which is highly leveraged (730% above the sector average of 2.4x). Net debt stands at $244M ($277M total debt minus $33M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.94 | 0.94 | 0.77 | 0.78 | 1.07 | 1.93 | 2.49 | 1.67 | 2.75 | 0.94 |
| Debt / EBITDA | 20.20 | 20.20 | 4.10 | 3.50 | 3.46 | 3.91 | 3.41 | 2.81 | 4.53 | 19.23 |
| Net Debt / Equity | — | 0.83 | 0.64 | 0.63 | 0.86 | 1.53 | 2.04 | 1.61 | 2.68 | 0.92 |
| Net Debt / EBITDA | 17.81 | 17.81 | 3.43 | 2.84 | 2.78 | 3.10 | 2.79 | 2.71 | 4.42 | 18.80 |
| Debt / FCF | — | 6.91 | 11.96 | — | — | — | 25.46 | 3.81 | 7.00 | 4.14 |
| Interest Coverage | -0.08 | -0.08 | 1.27 | 2.23 | 2.16 | 1.76 | 1.33 | 0.57 | — | — |
BIOX Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.91x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 1.33x to 0.91x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.91 | 0.91 | 1.24 | 1.33 | 1.34 | 1.26 | 1.26 | 0.84 | 0.72 | 1.26 |
| Quick Ratio | 0.65 | 0.65 | 0.86 | 0.86 | 0.77 | 0.88 | 1.03 | 0.61 | 0.56 | 0.81 |
| Cash Ratio | 0.10 | 0.10 | 0.17 | 0.20 | 0.17 | 0.28 | 0.43 | 0.03 | 0.02 | 0.02 |
| Asset Turnover | — | 0.44 | 0.55 | 0.51 | 0.63 | 0.52 | 0.58 | 0.66 | 0.68 | 0.39 |
| Inventory Turnover | 2.26 | 2.26 | 2.24 | 1.70 | 1.60 | 1.83 | 3.02 | 3.14 | 3.98 | 1.91 |
| Days Sales Outstanding | — | 194.66 | 169.64 | 161.26 | 142.33 | 175.08 | 164.85 | 134.87 | 144.61 | 162.33 |
BIOX Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Bioceres Crop Solutions Corp. returns 3.9% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 0.5% | 2.2% | — | — | 1.5% | — | — | — |
| FCF Yield | 100.0% | 12.5% | 2.7% | — | — | — | 2.2% | 16.2% | 4.7% | — |
| Buyback Yield | 3.9% | 0.3% | 0.1% | 0.4% | 0.0% | 0.6% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 3.9% | 0.3% | 0.1% | 0.4% | 0.0% | 0.6% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $63M | $63M | $63M | $42M | $39M | $36M | $30M | $28M | $28M |
Peer Comparison
Compare BIOX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 BIOXYou | $24M | -0.5 | 19.5 | 0.7 | 39.1% | -1.1% | -16.0% | -0.5% | 20.2 |
 PGEN | $1B | -3.4 | — | — | 37.1% | -1100.8% | -843.6% | -1553.8% | — |
 FMC | $1B | -0.6 | — | — | 37.0% | -54.4% | -67.8% | -21.2% | — |
 CTVA | $53B | 49.1 | 13.3 | 18.7 | 43.6% | 15.1% | 4.5% | 8.5% | 0.7 |
 AVD | $76M | -1.5 | 7.8 | — | 28.6% | 2.7% | -23.4% | 2.7% | 5.9 |
 HALO | $8B | 26.8 | 11.2 | 12.6 | 78.1% | 58.4% | 153.6% | 32.1% | 2.4 |
 RKDA | $1M | -0.5 | — | — | 36.2% | -205.7% | -45.1% | -249.2% | — |
 DE | $159B | 31.9 | 20.2 | 49.2 | 36.5% | 18.8% | 20.5% | 7.8% | 6.0 |
 CF | $16B | 11.5 | 5.4 | 8.8 | 38.5% | 33.4% | 18.9% | 18.7% | 1.2 |
 MOS | $7B | 13.5 | 5.5 | — | 15.1% | 8.7% | 4.5% | 4.8% | 2.4 |
 NTR | $30B | 13.3 | 6.7 | 14.8 | 31.0% | 14.5% | 9.3% | 8.0% | 2.0 |
| Basic Materials Median | — | 23.6 | 11.0 | 29.0 | 30.9% | 10.3% | -0.0% | 4.6% | 2.4 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 9 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
BIOX — Frequently Asked Questions
Quick answers to the most common questions about buying BIOX stock.
What is Bioceres Crop Solutions Corp.'s P/E ratio?
Bioceres Crop Solutions Corp.'s current P/E ratio is -0.5x. The historical average is 55.1x.
What is Bioceres Crop Solutions Corp.'s EV/EBITDA?
Bioceres Crop Solutions Corp.'s current EV/EBITDA is 19.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.2x.
What is Bioceres Crop Solutions Corp.'s ROE?
Bioceres Crop Solutions Corp.'s return on equity (ROE) is -16.0%. The historical average is -10.0%.
Is BIOX stock overvalued?
Based on historical data, Bioceres Crop Solutions Corp. is trading at a P/E of -0.5x. Compare with industry peers and growth rates for a complete picture.
What are Bioceres Crop Solutions Corp.'s profit margins?
Bioceres Crop Solutions Corp. has 39.1% gross margin and -1.1% operating margin.
How much debt does Bioceres Crop Solutions Corp. have?
Bioceres Crop Solutions Corp.'s Debt/EBITDA ratio is 20.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.